Pathogenic germline variants in BRCA1 and BRCA2 (gBRCA+) confer an elevated risk (57% and 49%, respectively) of developing breast cancer1 and are found across breast cancer subtypes2. The gene discussed is BRCA2; the disease is breast cancer.